Advanced 340B Education: Staying Informed and Empowered

SPONSORED CONTENT

The 340B drug pricing program is a critical resource for covered entities and stakeholders, providing access to affordable medications for vulnerable patient populations. To ensure that you are well equipped to navigate the complexities of the program, the Apexus Advanced 340B Operations Certificate Program is excited to introduce our new advanced 340B education offerings! These programs aim to provide you with comprehensive and up-to-date information on the latest trends and hot topics in the 340B landscape.

Master Classes: A Sneak Peek into Advanced 340B Education

Stay ahead of the curve by signing up for our master classes presented by the Apexus Advanced 340B Operations Certificate Program, held quarterly at no charge. Each master class is designed to cover the most relevant and timely developments and challenges facing 340B stakeholders. Whether you are a covered entity or a non-covered entity stakeholder, these

Read More »

340B Webinar—340B Legislation: Navigating Changes, Championing a Better Future

PharmaForce webinar April 18, 2024

SPONSORED CONTENT

Attention 340B Covered Entities: The 340B drug pricing program is entering an exciting phase of evolution. The SUSTAIN 340B Act and the 340B Patients Act demonstrate a strong commitment to refining the program, ensuring it serves patients effectively while maintaining accountability. This active legislative engagement, alongside legal discussions and state-level initiatives, signals a healthy process of improvement. Covered entities (CEs) now have a unique opportunity to collaborate with policymakers and shape the 340B program to best serve those in need.

This webinar will help you understand the potential changes, and equip you to advocate for your interests. Here’s what we’ll cover:

  • Manufacturer Restrictions: Analyze recent limitations and their potential impact on CEs.
  • Understanding Key Legislation: Compare and contrast the SUSTAIN 340B Act and the 340B Patients Act.
  • Examining the Arkansas Victory: Learn how this legal win could affect challenges to manufacturer restrictions.
  • Tracking State-Level Legislation: Discover which states support or
Read More »

Spring Cleaning of Your 340B Program

SPONSORED CONTENT

As we welcome the fresh energy of spring, now is the perfect time for 340B covered entities to conduct a thorough review and update of their 340B program. Ensuring your program’s compliance and efficiency is akin to spring cleaning—tidying up, organizing, and preparing for the year ahead. Below, we outline essential steps and checks to maintain the excellence of your 340B program as we transition to this new season.

1. Review Your State’s Medicaid Website for New BIN/PCN/Group Updates

It’s essential to regularly check the Medicaid website for your carve-in states, looking for any updates related to Billing Identifier Number (BIN), Processor Control Number (PCN), and group numbers. These details are crucial for accurately processing pharmacy claims and securing appropriate 340B discounts. Often, at the beginning of the year, Medicaid agencies will update their websites with the latest BIN/PCN/Group numbers based on recent contracting information with Medicaid Managed Care organizations.

2. Fiscal Year-End Specific Checks

For

Read More »

Bridging the primary care gap: The role of in-house pharmacies in today’s healthcare marketplace

Holly Russo, Maxor 340B

SPONSORED CONTENT

Healthcare leaders have a lot on their plates. Today’s healthcare landscape requires health care organizations to compete in attracting and retaining qualified employees, remain up to date on reimbursement changes, select and employ technologies to serve more patients in convenient ways, and adhere to quality standards to serve their communities.

With the need for pharmacy to become an integrated part of health care organizations and for leaders to be successful in achieving their objectives, organizations are turning to Maxor, a national provider of pharmacy services. Maxor’s been helping healthcare leaders tackle pharmacy challenges for more than 90 years.

Maxor partners with hospitals, health systems and grantee organizations (e.g. Community Health Centers, Ryan White Clinics, STD Clinics, FQHC and FQHC look-a-likes) to create fully customized solutions, allowing clients to realize clinical and financial benefits without the headache of running an onsite pharmacy. Not to mention, Maxor is a leading expert in 340B

Read More »

Veronica Brisco: A Leading Voice for Those with HIV and AIDS

SPONSORED CONTENT

Ms. Veronica Brisco is an advocate who “Speaks Out Loud” about her HIV diagnosis received in December 1999. Although diagnosed in 1999, she determined in May of 2011 to begin a personal journey to openly challenge the world to “Hear Me as I Speak Out Loud and Proud” in the fight against HIV and AIDS.

Ms. Brisco is a native of Philadelphia. Despite the challenges and obstacles of growing up in the inner city, she excelled and thrived in her environment with the love and support of family and friends. She was recruited by many colleges and universities after receiving an extensive number of academic scholarships and awards, including a four-year volleyball scholarship from the University of Maryland Eastern Shore (UMES). In 1985, Ms. Brisco was nominated and elected Miss UMES and featured in the Ebony Magazine as one of the reigning Queens of Historically Black Colleges and Universities. As a graduate of UMES

Read More »

Leveraging Cash Cards to Amplify Your Patient Impact

Larry Crowder headshot

SPONSORED CONTENT

With impending changes like the Senate’s bipartisan SUSTAIN 340B Act on the horizon, it’s becoming increasingly critical for covered entities to demonstrate tangible benefits and positive patient outcomes because of their participation in the 340B program. In the article below, Larry Crowder, Vice President of 340B at Cervey, explores an innovative strategy to ensure compliance and enhance the effectiveness of the 340B program – the cash card.

Understanding Cash Cards: Cash cards allow covered entities (CE) to provide financial assistance directly into the hand of those patients who need it most. These programs typically involve distributing a letter containing payor information – the BIN/PCN associated with a specific insurance or payment network to a patient who meets certain criteria which allows them to receive discounted or free prescriptions at a partnering retail pharmacy. Patients can use these “cards” to receive a lower co-pay and/or drug cost or,

Read More »

Key Considerations for the SUSTAIN 340B Act

SPONSORED CONTENT

On February 2, six senators known as the “Gang of Six” – John Thune, Debbie Stabenow, Shelley Moore Capito, Tammy Baldwin, Jerry Moran and Ben Cardin – unveiled a discussion draft bill intended to preserve the 340B program and codify in statute many of its operational provisions. The draft bill, titled Supporting Underserved and Strengthening Transparency, Accountability, and Integrity Now and for the Future of 340B Act (SUSTAIN 340B Act or SUSTAIN Act), was accompanied by an explanatory statement and request for information (RFI), with many questions for Covered Entities (CEs) to review and provide further responses to the Gang of Six.

Stakeholders were asked to review the RFI and provide additional responses, with comments due by April 1. As we approach the deadline for comments, it’s crucial to delve into the most critical elements of the bill and discuss next steps for 340B stakeholders.

340B’s Purpose (Section 2)

Read More »

For Covered Entities, Integrated Care is No Longer an Option

SPONSORED CONTENT

While health leaders have touted the “whole health” approach of integrated healthcare for decades as a way to provide patients with better, more cost-effective care, the COVID-19 pandemic significantly accelerated the adoption and implementation of this model by prompting rapid expansions in telehealth and highlighting the importance of cross-functional collaboration of medical specialties.

In a changing 340B environment, why should covered entities leverage this model to secure their missions and better serve their communities? Dr. Jennifer Peña, medical director at Q Care Plus (an Avita Care Solutions company) and a former White House physician, explains below and includes actionable tips for entities at all stages of adopting integrated care.

To make sure we’re all on the same page in terms of definition, how would you describe an integrated healthcare model as it applies to covered

Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report